Arthritis, Psoriatic Clinical Trial
Official title:
A Multicentre, Randomised, Double-blind, Placebo Controlled Phase III Study of Subcutaneously Administered Onercept in the Treatment and Re-treatment of Subjects With Moderate to Severe Plaque Psoriasis
The is a double-blind, placebo-controlled, randomized, and multicenter study consisting of a first treatment (FT) period followed by either an observation (OB) period and a re-treatment (RT) period or an open-label (OL) treatment period, depending on FT period response, and a 4-week safety follow-up (FU) period. The purpose of this study is to evaluate the safety and efficacy of onercept, to be administered as 150 milligram (mg) three times a week, compared to matching placebo, for the induction of remission in subjects with moderate to severe plaque psoriasis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02181673 -
A Study of Golimumab in Participants With Active Psoriatic Arthritis
|
Phase 3 | |
| Recruiting |
NCT04936308 -
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
|
Phase 3 | |
| Withdrawn |
NCT03625089 -
Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis
|
N/A | |
| Recruiting |
NCT05571696 -
Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases
|
N/A | |
| Active, not recruiting |
NCT05071664 -
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
|
Phase 2 | |
| Completed |
NCT00938015 -
Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis
|
N/A | |
| Suspended |
NCT03703934 -
Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls
|
||
| Recruiting |
NCT05092269 -
A Long-term Extension Study of Ustekinumab in Pediatric Participants
|
Phase 3 | |
| Terminated |
NCT05083078 -
A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis
|
Phase 1 | |
| Completed |
NCT02436785 -
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?
|
N/A | |
| Completed |
NCT02294227 -
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
|
Phase 3 | |
| Completed |
NCT00998829 -
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
|
N/A | |
| Completed |
NCT00760669 -
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
|
Phase 4 | |
| Completed |
NCT00367237 -
Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)
|
Phase 3 | |
| Completed |
NCT00051623 -
A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
|
Phase 3 | |
| Withdrawn |
NCT04680676 -
A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis
|
Phase 2 | |
| Completed |
NCT03008590 -
Low Dose Naltrexone for Chronic Pain From Arthritis
|
Phase 2 | |
| Recruiting |
NCT05657847 -
Novel Complex Radiodiagnostics of Peripherial Arthropathies
|
||
| Completed |
NCT02875184 -
A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands
|
||
| Active, not recruiting |
NCT03942783 -
WORKWELL: Testing Work Advice for People With Arthritis
|
N/A |